Effect of Cyclosporine on Lesion Growth and Infarct Size within the White and Gray Matter
BackgroundIn a recent trial, cyclosporine A (CsA) failed to reduce infarct size in acute stroke patients treated with intravenous thrombolysis. White matter (WM) and gray matter (GM) may have distinct vulnerability to ischemia and response to therapy. Using final infarct size and lesion growth as en...
Main Authors: | Tae-Hee Cho, Elodie Ong, Nathan Mewton, Julien Bouvier, Fabien Chauveau, Thomas Ritzenthaler, Laura Mechtouff, Laurent Derex, Marielle Buisson, Yves Berthezène, Michel Ovize, Norbert Nighoghossian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-04-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fneur.2017.00151/full |
Similar Items
-
Matrix Metalloproteinase-9 Relationship With Infarct Growth and Hemorrhagic Transformation in the Era of Thrombectomy
by: Laura Mechtouff, et al.
Published: (2020-06-01) -
Combining Intravenous Thrombolysis and Antithrombotic Agents in Stroke: An Update
by: Laurent Derex, et al.
Published: (2018-01-01) -
Specific inflammatory profile of acute ischemic stroke patients with left atrial enlargement
by: Julia Fontaine, et al.
Published: (2023-07-01) -
Contrast quality control for segmentation task based on deep learning models—Application to stroke lesion in CT imaging
by: Juliette Moreau, et al.
Published: (2025-02-01) -
In vitro and in vivo models of cerebral ischemia show discrepancy in therapeutic effects of M2 macrophages.
by: Virginie Desestret, et al.
Published: (2013-01-01)